Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03942432Completed
Open-label trial in dysmetabolic iron overload syndrome, sponsored by CHU Rennes. Primary endpoint: Fasting blood glycemia at 5 years. Started Jun 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03942432.